Public health agencies lecture the American public to ‘trust the science.’
That means study the data and make a critical analysis of peer-reviewed studies, right?
But for one FDA vaccine-advisory panelist, a gut feeling is sufficient.
The 19-member advisory committee made an unanimous decision to authorize Moderna boosters for individuals 65+, with underlying conditions, and 18+ at high-risk exposure.
Trending: Noah’s Nightly Newsletter – 5/26/22
It’s an identical decision the panel made with the Pfizer boosters.
For the Moderna booster, Dr. Patrick Moore of the University of Pittsburgh School of Medicine admitted the data wasn’t strong.
The professor of molecular genetics and biochemistry said “it’s more of a gut feeling.”
They vote unanimously to authorize it. Here’s what one of them said: “It’s more a gut feeling rather than based on really truly serious data,” said Patrick Moore, a member of the committee. “The data itself is not strong…” https://t.co/q5kMhW4QMl
— Brit Hume (@brithume) October 15, 2021
— The Resistance 1776 (@TR76News) October 17, 2021
"The data itself is not strong, but it is certainly going in the direction that is supportable of this vote," said Dr. Patrick Moore of the Univ of Pittsburgh SOM. Moore said he voted in favor of Moderna boosters based largely on a "gut feeling rather than truly serious data."
— Mike Banks MD (@Mike_BanksMD) October 14, 2021
BREAKING: FDA advisors vote 19-0 to endorse Moderna booster for the same groups as they previously gave authorization for Pfizer (65+, or 18+ with high risk due to occupational exposure or medical condition). Note that this is for a half dose compared to original vaccine.
— Leana Wen, M.D. (@DrLeanaWen) October 14, 2021
JUST IN: An advisory panel unanimously recommended the FDA authorize a Moderna booster for people 65 years and older as well as younger adults who are at risk of severe COVID or face high work-related risk.https://t.co/AYAipvB4JR
— NPR (@NPR) October 14, 2021
From The Wall Street Journal via Information Liberation:
Vaccine experts advising the Food and Drug Administration voted 19 to 0 Thursday to recommend authorization of an extra dose of Moderna Inc.’s MRNA Covid-19 shot, a key step in making booster doses available to millions more people.
A vaccine-advisory panel voted in favor of giving a Moderna booster shot at least six months after the second dose, to adults 65 years and older, as well as adults under 65 who are at high risk of severe Covid-19 or serious complications because of their jobs, living conditions or underlying medical conditions.
[…] Members of the FDA’s vaccine-advisory panel supported Moderna’s booster dose even though the evidence for it was from a small study and had mixed results.
“It’s more a gut feeling rather than based on really truly serious data,” said Patrick Moore, a member of the committee and a professor of molecular genetics and biochemistry at the University of Pittsburgh School of Medicine. “The data itself is not strong, but it is certainly going in the direction that is supportive of this vote.”
Remember, follow the $cience.
— New York Post (@nypost) October 8, 2021
Don’t worry about the record profits for Big Pharma!